Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma

Figure 16

Differential analysis of IC50 value of sunitinib, gefitinib, nilotinib, rapamycin, mitomycin.C, paclitaxel, vinblastine, salubrinal, parthenolide, metformin, embelin, and thapsigargin between high- and low-risk groups. IC50: half-maximal inhibitory concentration.